10/28/2025Metis TechBio to File China NDA for AI-Designed PBA Drug MTS-004

10/28/2025Innovent's Mazdutide Tops Ozempic in Phase III Diabetes and Obesity Tr...

10/27/2025Hengrui's TROP-2 ADC SHR-A1921 Shows Promising Activity in First-in-Hu...

10/27/2025Zai Lab Shares Phase 1 Data for DLL3-Targeted ADC Rivaling Amgen's Imd...

10/27/2025Alphamab Doses First Patient in Phase 1 Trial of PD-L1/αvβ6 Bispecif...

10/27/2025Lanma's LM103 TIL Therapy Moves Into Phase 2 After Promising Phase 1 D...

10/24/2025Chinese Biotech Launches Genos, an Advanced Human-Centric Genomic AI M...

10/24/2025METiS's AI-Designed MTS-004 Becomes China's First AI-Enabled Formulati...

10/24/2025Terns Halts Development of TERN-601 After Phase 2 Results

10/24/2025Boehringer Ingelheim's Jascayd Wins NMPA Approval for IPF

10/22/2025GenScript Wins NMPA IND Nod for Bispecific ADC GenSci139

10/22/2025Zai Lab Launches First Phase 3 Trial of DLL3-Targeted ADC ZL-1310 in R...

10/22/2025Multitude Reports Strong Efficacy for CD44v9-Targeted ADC AMT-116 at E...

10/21/2025Henlius' PD-L1 ADC HLX43 Receives Orphan Drug Designation in the U.S.

10/21/2025CSPC's JSKN003 Granted Breakthru Therapy Designation in China

10/21/2025Kelun-Biotech’s Sacituzumab Tirumotecan Shows Strong Phase 3 Results

10/21/2025RemeGen's Disitamab Vedotin Plus Toripalimab Delivers Breakthru First-...

10/21/2025Merck KGaA and Abbisko Report Strong Phase 3 Results for Pimicotinib a...

10/20/2025Kelun Gains China Approval for First Homegrown HER2 Breast Cancer ADC

10/20/2025Akeso Reports Strong China Data for Ivonescimab in Lung Cancer

10/17/2025LEO Pharma's Anzupgo Cream NDA Accepted in China

10/17/2025RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...

10/16/2025Belite Bio Secures Priority Review from China's NMPA for Tinlarebant

10/16/2025Qilu Presents Promising Phase I Data for AR PROTAC Degrader QLH12016

10/15/2025Sino Biopharma's TQB2102 Receives Breakthru Therapeutic Designation in...

10/14/2025GSK's Shingrix Wins Chinese Approval for Expanded Use

10/14/2025Biokin and SystImmune Present Promising Early Data for EGFR×HER3 Bisp...

10/14/2025Multitude Reports Updated Safety and Dose Findings for AMT-116 at ESMO...

10/14/2025AskBio Reports Promising Safety Results from First Cohort of AB-1003 G...

10/13/2025Lepu Reports Early Clinical Data for ADC Programs in Various Cancers

Page:1/20 Total number of articles:596: [First][<<] [1] [2] [3] [4] [5] [>>] [End]